| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total operating costs and expenses | 158,496 | 156,854 | 154,338 | 151,815 |
| Operating income (loss) | -36,021 | -39,521 | -37,865 | -32,092 |
| Financial income (expenses), net | 5,999 | 4,542 | 7,570 | 10,507 |
| Income (loss) before income tax | -30,022 | -34,979 | -30,295 | -21,585 |
| Income tax | 7,248 | 5,160 | 4,024 | 8,985 |
| Net income (loss) | -37,270 | -40,139 | -34,319 | -30,570 |
| Basic net income (loss) per ordinary share | -0.33 | -0.36 | -0.31 | -0.28 |
| Diluted net income (loss) per ordinary share | -0.33 | -0.36 | -0.31 | -0.28 |
| Weighted average number of ordinary shares used in computing basic net income (loss) per share (in shares) | 111,908,252 | 111,572,191 | 110,281,832 | 108,247,716 |
| Weighted average number of ordinary shares used in computing diluted net income (loss) per share (in shares) | 111,908,252 | 111,572,191 | 110,281,832 | 108,247,716 |
NovoCure Ltd (NVCR)
NovoCure Ltd (NVCR)